TET2 c.4019T>G ;(p.L1340R)

Variant ID: 4-106182980-T-G

NM_001127208.2(TET2):c.4019T>G;(p.L1340R)

This variant was identified in 9 publications

View GRCh38 version.




Publications:


TET2 truncating mutations predict a worse outcome in blastic plasmacytoid dendritic cell neoplasm.

Blood Advances
Beird, Hannah C HC; Yin, C Cameron CC; Khoury, Joseph D JD; Pierce, Sherry R SR; Abbas, Hussein A HA; Zhao, Li L; Skwarska, Anna A; Qazilbash, Muzaffar H MH; Konopleva, Marina Y MY; Futreal, Andrew A; Pemmaraju, Naveen N
Publication Date: 2023-01-23

Variant appearance in text: TET2: L1340R
PubMed Link: 36689729
Variant Present in the following documents:
  • BLOODA_ADV-2022-007879-mmc1.pdf
View BVdb publication page



Predictive mutation signature of immunotherapy benefits in NSCLC based on machine learning algorithms.

Frontiers In Immunology
Liu, Zhichao Z; Lin, Guo G; Yan, Zeping Z; Li, Linduo L; Wu, Xingchen X; Shi, Jingrong J; He, Jianxing J; Zhao, Lei L; Liang, Hengrui H; Wang, Wei W
Publication Date: 2022

Variant appearance in text: TET2: 4019T>G; L1340R
PubMed Link: 36238300
Variant Present in the following documents:
  • Table_1.xlsx, sheet 4
View BVdb publication page



EPHA5 mutation was associated with adverse outcome of atezolizumab treatment in late-stage non-small cell lung cancers.

Bmc Pulmonary Medicine
Li, Zhenxiang Z; Zhou, Qing Q; Wang, Qi Q; Wang, Haiyong H; Yue, Weiming W
Publication Date: 2022-09-19

Variant appearance in text: TET2: 4019T>G; L1340R
PubMed Link: 36123678
Variant Present in the following documents:
  • 12890_2022_2161_MOESM2_ESM.xlsx, sheet 1
View BVdb publication page



Mutational spectrum and prognosis in Chinese patients with prefibrotic primary myelofibrosis.

Ejhaem
Cheng, Chi-Keung CK; Lai, Jennifer W Y JWY; Yung, Yuk-Lin YL; Chan, Hoi-Yun HY; Wong, Raymond S M RSM; Chan, Natalie P H NPH; Cheung, Joyce S JS; Luo, Xi X; Pitts, Herbert-Augustus HA; Ng, Margaret H L MHL
Publication Date: 2022-02

Variant appearance in text: TET2: 4019T>G; L1340R; rs1160334208
PubMed Link: 35846205
Variant Present in the following documents:
  • JHA2-3-184-s002.xlsx, sheet 1
View BVdb publication page



TET2 missense variants in human neoplasia. A proposal of structural and functional classification.

Molecular Genetics & Genomic Medicine
Bussaglia, Elena E; Antón, Rosa R; Nomdedéu, Josep F JF; Fuentes-Prior, Pablo P
Publication Date: 2019-07

Variant appearance in text: TET2: 4019T>G; Leu1340Arg
PubMed Link: 31187595
Variant Present in the following documents:
View BVdb publication page



Overlap at the molecular and immunohistochemical levels between angioimmunoblastic T-cell lymphoma and a subgroup of peripheral T-cell lymphomas without specific morphological features.

Oncotarget
Manso, Rebeca R; González-Rincón, Julia J; Rodríguez-Justo, Manuel M; Roncador, Giovanna G; Gómez, Sagrario S; Sánchez-Beato, Margarita M; Piris, Miguel A MA; Rodríguez-Pinilla, Socorro M SM
Publication Date: 2018-03-23

Variant appearance in text: TET2: 4019T>G; Leu1340Arg
PubMed Link: 29662631
Variant Present in the following documents:
  • Main text
  • oncotarget-09-16124-s002.xls, sheet 1
  • oncotarget-09-16124.pdf
View BVdb publication page



Enteropathy-associated T cell lymphoma subtypes are characterized by loss of function of SETD2.

The Journal Of Experimental Medicine
Moffitt, Andrea B AB; Ondrejka, Sarah L SL; McKinney, Matthew M; Rempel, Rachel E RE; Goodlad, John R JR; Teh, Chun Huat CH; Leppa, Sirpa S; Mannisto, Susanna S; Kovanen, Panu E PE; Tse, Eric E; Au-Yeung, Rex K H RKH; Kwong, Yok-Lam YL; Srivastava, Gopesh G; Iqbal, Javeed J; Yu, Jiayu J; Naresh, Kikkeri K; Villa, Diego D; Gascoyne, Randy D RD; Said, Jonathan J; Czader, Magdalena B MB; Chadburn, Amy A; Richards, Kristy L KL; Rajagopalan, Deepthi D; Davis, Nicholas S NS; Smith, Eileen C EC; Palus, Brooke C BC; Tzeng, Tiffany J TJ; Healy, Jane A JA; Lugar, Patricia L PL; Datta, Jyotishka J; Love, Cassandra C; Levy, Shawn S; Dunson, David B DB; Zhuang, Yuan Y; Hsi, Eric D ED; Dave, Sandeep S SS
Publication Date: 2017-05-01

Variant appearance in text: TET2: L1340R
PubMed Link: 28424246
Variant Present in the following documents:
  • JEM_20160894_TableS1-S10.xlsx, sheet 1
View BVdb publication page



Applicability of next-generation sequencing to decalcified formalin-fixed and paraffin-embedded chronic myelomonocytic leukaemia samples.

International Journal Of Clinical And Experimental Pathology
Bernard, Veronica V; Gebauer, Niklas N; Dinh, Thomas T; Stegemann, Judith J; Feller, Alfred C AC; Merz, Hartmut H
Publication Date: 2014

Variant appearance in text: TET2: L1340R
PubMed Link: 24817963
Variant Present in the following documents:
  • Main text
View BVdb publication page



Evaluation of allelic strength of human TET2 mutations and cooperation between Tet2 knockdown and oncogenic Nras mutation.

British Journal Of Haematology
Chang, Yuan-I YI; Damnernsawad, Alisa A; Allen, Laura K LK; Yang, David D; Ranheim, Erik A EA; Young, Ken H KH; Zhang, Jingfang J; Kong, Guangyao G; Wang, Jinyong J; Liu, Yangang Y; Fu, Hsu-Yuan HY; Yang, Chii-Shen CS; Guo, Junjie J; Song, Hongjun H; Zhang, Jing J
Publication Date: 2014-08

Variant appearance in text: TET2: L1340R
PubMed Link: 24697267
Variant Present in the following documents:
  • Main text
View BVdb publication page